secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syndax Pharmaceuticals Inc (SNDX)
CIK:        0001395937
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001193125-25-326961
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syndax amends Bylaws to move to uncertificated shares effective Dec 18, 2025
----------------------------------------------------------------------------

- Board approved Bylaw amendment on Dec 18, 2025 requiring all future share issuances to be uncertificated.
- Existing physical certificates issued prior to Dec 18, 2025 remain valid until surrendered.
- Amendment is administrative; no change to shareholder rights or capital structure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1395937/000119312525326961/0001193125-25-326961-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1395937/000119312525326961/sndx-20251218.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-326961

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer